Cypress Capital Group’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-3,536
| Closed | -$296K | – | 283 |
|
|
2021
Q1 | $296K | Sell |
3,536
-203
| -5% | -$17K | 0.04% | 237 |
|
|
2020
Q4 | $341K | Sell |
3,739
-371
| -9% | -$33.8K | 0.05% | 231 |
|
|
2020
Q3 | $328K | Sell |
4,110
-444
| -10% | -$35.4K | 0.05% | 210 |
|
|
2020
Q2 | $315K | Buy |
+4,554
| New | +$315K | 0.06% | 205 |
|
|
2016
Q3 | – | Sell |
-20,655
| Closed | -$687K | – | 183 |
|
|
2016
Q2 | $687K | Sell |
20,655
-3,987
| -16% | -$133K | 0.16% | 106 |
|
|
2016
Q1 | $725K | Buy |
24,642
+3,474
| +16% | +$102K | 0.18% | 101 |
|
|
2015
Q4 | $557K | Sell |
21,168
-9,900
| -32% | -$261K | 0.13% | 119 |
|
|
2015
Q3 | $736K | Buy |
31,068
+294
| +1% | +$6.97K | 0.18% | 101 |
|
|
2015
Q2 | $731K | Hold |
30,774
| – | – | 0.17% | 111 |
|
|
2015
Q1 | $731K | Buy |
30,774
+4,584
| +18% | +$109K | 0.17% | 110 |
|
|
2014
Q4 | $556K | Buy |
26,190
+8,112
| +45% | +$172K | 0.13% | 127 |
|
|
2014
Q3 | $308K | Buy |
+18,078
| New | +$308K | 0.07% | 172 |
|